Macerich, the third-largest US shopping mall owner, rejected a $14.39 billion unsolicited offer from larger rival Simon Property Group, saying the proposal “substantially undervalues” the company.
Macerich also said on Tuesday it adopted a poison pill, or a shareholder rights plan, with a 10 percent trigger and changed its board structure to thwart a hostile takeover.
Shares of Macerich, which received the $91 per share offer earlier this month, fell as much as 5 percent to $90.29 in early trading. Including debt, the offer was valued at $22.4 billion.
“Macerich’s rejection is based on a rosy view of its future prospects,” Simon Property Chief Executive David Simon said in a statement, calling the rejection an “extreme, scorched-earth response”.
Full Content: The New York Times
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
South Africa Approves Canal+ MultiChoice Deal
May 21, 2025 by
CPI
WhatsApp Co-Founder Undermines Antitrust Allegations Against Meta in Court Testimony
May 21, 2025 by
CPI
OpenAI Acquires Jony Ive’s io for $6.4B to Pioneer Post-Smartphone Devices
May 21, 2025 by
CPI
Dior Commits €2 Million to Labor Initiatives in Italian Antitrust Settlement
May 21, 2025 by
CPI
Indonesia’s Antitrust Watchdog Probes Potential Risks of Grab-GoTo Merger
May 21, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Industrial Policy
May 21, 2025 by
CPI
Industrial Strategy and the Role of Competition – Taking a Business Lens
May 21, 2025 by
Marcus Bokkerink
Industrial Policy, Antitrust, and Economic Growth: Some Observations
May 21, 2025 by
David S. Evans
Bolder by Design: Crafting Pro-Competitive Industrial Policies For Complex Challenges
May 21, 2025 by
Antonio Capobianco & Beatriz Marques
Competition-Friendly Industrial Policy
May 21, 2025 by
Philippe Aghion, Mathias Dewatripont & Patrick Legros